We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Standardization of CD3+ T Cell Dose for Patients Receiving Allogeneic Peripheral Blood Stem Cell Transplantation From Matched Related Donors

This study is currently recruiting participants.
Verified November 2017 by Ayman Saad, University of Alabama at Birmingham
Sponsor:
ClinicalTrials.gov Identifier:
NCT00959140
First Posted: August 14, 2009
Last Update Posted: November 6, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
Collaborator:
Miltenyi Biotec, Inc.
Information provided by (Responsible Party):
Ayman Saad, University of Alabama at Birmingham
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: October 2021
  Estimated Primary Completion Date: October 2019 (Final data collection date for primary outcome measure)